Astra Pharmaceuticals

AstraZeneca is a leading global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal, metabolism, and respiratory and immunology. Formed through the 1999 merger of the Swedish company Astra AB and the British Zeneca Group, the company has a robust portfolio of blockbuster drugs such as Tagrisso, Imfinzi, Farxiga, and Lynparza. AstraZeneca operates in over 100 countries and maintains significant R&D centers in the United Kingdom, United States, and Sweden. The company gained significant global prominence for its development of the Vaxzevria COVID-19 vaccine in collaboration with the University of Oxford. AstraZeneca continues to expand its pipeline through strategic acquisitions, such as Alexion Pharmaceuticals, to bolster its presence in rare diseases.